Pazopanib together with 6–8 cycles of sintilimab followed by single use of pazopanib in the second-line treatment of advanced renal cell carcinoma
@article{TAU70141,
author = {Xiaolin Lu and Weijie Gu and Guohai Shi and Dingwei Ye},
title = {Pazopanib together with 6–8 cycles of sintilimab followed by single use of pazopanib in the second-line treatment of advanced renal cell carcinoma},
journal = {Translational Andrology and Urology},
volume = {10},
number = {5},
year = {2021},
keywords = {},
abstract = {},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/70141}
}